drugset / Trial / NCT02096874

Bevacizumab and Peripheral Retinal Changes on Wide Field Angiography in Diabetic Macular Edema

NCT02096874

Phase 4 Completed 50 enrolled King Khaled Eye Specialist Hospital
NaSingle-groupOpen-labelTreatment

Summary

Ultra-wide field fluorescein angiography can detect the response of anti VGEF therapy such as Avastin on retinal ischemia in the setting of diabetic macular edema.

Timeline

Start
2013-06
Primary completion
2014-12
Completion
2015-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Bevacizumab Monoclonal antibody 1.25 mg Intravitreal